• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.38% Nasdaq Down0.41%

    Cardica Inc. (CRDC)

    0.27 Up 0.01(1.89%) Oct 12 - Nasdaq Real Time Price
    ProfileGet Profile for:
    Cardica Inc.
    900 Saginaw Drive
    Redwood City, CA 94063
    United States - Map
    Phone: 650-364-9975
    Fax: 650-364-3134
    Website: http://www.cardica.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:44

    Business Summary 

    Cardica, Inc. designs, manufactures, and markets automated anastomotic systems for use by cardiac surgeons to perform coronary bypass surgery in the United States and internationally. It offers C-Port xA Anastomosis systems to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis systems to enable automated anastomoses to be performed as part of CABG procedures; and PAS-Port Proximal Anastomosis systems to perform an end-to-side proximal anastomosis between a saphenous vein and the aorta. The company also offers endoscopic microcutter products comprising MicroCutter XCHANGE 30 for use by thoracic, pediatric, bariatric, colorectal, and general surgeons. In addition, it licenses its intellectual property in the robotics field in diagnostic or therapeutic medical procedures. Cardica, Inc. markets its products through its direct sales force, as well as through independent manufacturersÂ’ representatives and distributors. The company was formerly known as Vascular Innovations, Inc. and changed its name to Cardica, Inc. in November 2001. Cardica, Inc. was founded in 1997 and is headquartered in Redwood City, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cardica Inc.

    Key Executives 
    Dr. Bernard A. Hausen M.D., Ph.D., 55
    Co-Founder, Chief Exec. Officer, Pres, Chief Medical Officer, Director and Member of Strategic Review Committee
    Mr. Liam J. Burns , 49
    VP of Sales and Marketing
    Mr. Robert Y. Newell IV, 67
    Chief Financial Officer, VP of Fin. and Sec.
    Mr. Gregory P. Watson , 59
    VP of Operations
    Dr. Lee L. Swanstrom M.D., FACS,
    Medical Director
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders